Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics

by Ysios Capital

Vivet is supported by international life science investors including Novartis Venture Fund, Roche Venture Fund, HealthCap, Columbus Venture Partners, Ysios Capital, Kurma Partners and Idinvest Partner...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

PIB Group, participado por Apax y Carlyl...

by PIB Group

PIB Group ha anunciado la adquisición de Fabroker, consolidando así ...

Photos Stream